Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 47

1.

Recent History of Serious Fall Injuries and Posttransplant Outcomes among U.S. Kidney Transplant Recipients.

Lynch RJ, Patzer RE, Pastan SO, Bowling CB, Plantinga LC.

Transplantation. 2018 Sep 21. doi: 10.1097/TP.0000000000002463. [Epub ahead of print]

PMID:
30247319
2.

Racial disparities in preemptive referral for kidney transplantation in Georgia.

Gander JC, Zhang X, Plantinga L, Paul S, Basu M, Pastan SO, Gibney E, Hartmann E, Mulloy L, Zayas C, Patzer RE.

Clin Transplant. 2018 Sep;32(9):e13380. doi: 10.1111/ctr.13380. Epub 2018 Aug 26.

3.

iChoose Kidney for Treatment Options: Updated Models for Shared Decision Aid.

Gander JC, Basu M, McPherson L, Garber MD, Pastan SO, Manatunga A, Arriola KJ, Patzer RE.

Transplantation. 2018 Sep;102(9):e370-e371. doi: 10.1097/TP.0000000000002301. No abstract available.

PMID:
29979349
4.

Factors leading to the discard of deceased donor kidneys in the United States.

Mohan S, Chiles MC, Patzer RE, Pastan SO, Husain SA, Carpenter DJ, Dube GK, Crew RJ, Ratner LE, Cohen DJ.

Kidney Int. 2018 Jul;94(1):187-198. doi: 10.1016/j.kint.2018.02.016. Epub 2018 May 5.

PMID:
29735310
5.

Awareness of Racial Disparities in Kidney Transplantation among Health Care Providers in Dialysis Facilities.

Kim JJ, Basu M, Plantinga L, Pastan SO, Mohan S, Smith K, Melanson T, Escoffery C, Patzer RE.

Clin J Am Soc Nephrol. 2018 May 7;13(5):772-781. doi: 10.2215/CJN.09920917. Epub 2018 Apr 12.

PMID:
29650714
6.

Racial/ethnic disparities in waitlisting for deceased donor kidney transplantation 1 year after implementation of the new national kidney allocation system.

Zhang X, Melanson TA, Plantinga LC, Basu M, Pastan SO, Mohan S, Howard DH, Hockenberry JM, Garber MD, Patzer RE.

Am J Transplant. 2018 Aug;18(8):1936-1946. doi: 10.1111/ajt.14748. Epub 2018 Apr 18.

PMID:
29603644
7.

Transplant Center Patient Navigator and Access to Transplantation among High-Risk Population: A Randomized, Controlled Trial.

Basu M, Petgrave-Nelson L, Smith KD, Perryman JP, Clark K, Pastan SO, Pearson TC, Larsen CP, Paul S, Patzer RE.

Clin J Am Soc Nephrol. 2018 Apr 6;13(4):620-627. doi: 10.2215/CJN.08600817. Epub 2018 Mar 26.

PMID:
29581107
8.

Association of Serious Fall Injuries among United States End Stage Kidney Disease Patients with Access to Kidney Transplantation.

Plantinga LC, Lynch RJ, Patzer RE, Pastan SO, Bowling CB.

Clin J Am Soc Nephrol. 2018 Apr 6;13(4):628-637. doi: 10.2215/CJN.10330917. Epub 2018 Mar 6.

PMID:
29511059
9.

Awareness of the New Kidney Allocation System among United States Dialysis Providers with Low Waitlisting.

Patzer RE, Basu M, Smith KD, Plantinga L, Mohan S, Escoffery C, Kim JJ, Melanson T, Pastan SO.

Am J Nephrol. 2018;47(2):115-119. doi: 10.1159/000486648. Epub 2018 Feb 22.

10.

Standardized Transplantation Referral Ratio to Assess Performance of Transplant Referral among Dialysis Facilities.

Paul S, Plantinga LC, Pastan SO, Gander JC, Mohan S, Patzer RE.

Clin J Am Soc Nephrol. 2018 Feb 7;13(2):282-289. doi: 10.2215/CJN.04690417. Epub 2018 Jan 25.

11.

Process evaluation of the RaDIANT community study: a dialysis facility-level intervention to increase referral for kidney transplantation.

Hamoda RE, Gander JC, McPherson LJ, Arriola KJ, Cobb L, Pastan SO, Plantinga L, Browne T, Hartmann E, Mulloy L, Zayas C, Krisher J, Patzer RE.

BMC Nephrol. 2018 Jan 15;19(1):13. doi: 10.1186/s12882-017-0807-z.

12.

Dialysis facility staff perceptions of racial, gender, and age disparities in access to renal transplantation.

Lipford KJ, McPherson L, Hamoda R, Browne T, Gander JC, Pastan SO, Patzer RE.

BMC Nephrol. 2018 Jan 10;19(1):5. doi: 10.1186/s12882-017-0800-6.

13.

United States Dialysis Facilities With a Racial Disparity in Kidney Transplant Waitlisting.

Gander JC, Plantinga L, Zhang R, Mohan S, Pastan SO, Patzer RE.

Kidney Int Rep. 2017 May 26;2(5):963-968. doi: 10.1016/j.ekir.2017.05.010. eCollection 2017 Sep. No abstract available.

14.

Characteristics and Performance of Unilateral Kidney Transplants from Deceased Donors.

Husain SA, Chiles MC, Lee S, Pastan SO, Patzer RE, Tanriover B, Ratner LE, Mohan S.

Clin J Am Soc Nephrol. 2018 Jan 6;13(1):118-127. doi: 10.2215/CJN.06550617. Epub 2017 Dec 7.

15.

Emergency department use among kidney transplant recipients in the United States.

Lovasik BP, Zhang R, Hockenberry JM, Schrager JD, Pastan SO, Adams AB, Mohan S, Larsen CP, Patzer RE.

Am J Transplant. 2018 Apr;18(4):868-880. doi: 10.1111/ajt.14578. Epub 2017 Dec 20.

PMID:
29116680
16.

Hospitalization Among Individuals Waitlisted For Kidney Transplant.

Newman KL, Lynch RJ, Adams AB, Zhang R, Pastan SO, Patzer RE.

Transplantation. 2017 Dec;101(12):2913-2923. doi: 10.1097/TP.0000000000001839.

17.

Belatacept Combined With Transient Calcineurin Inhibitor Therapy Prevents Rejection and Promotes Improved Long-Term Renal Allograft Function.

Adams AB, Goldstein J, Garrett C, Zhang R, Patzer RE, Newell KA, Turgeon NA, Chami AS, Guasch A, Kirk AD, Pastan SO, Pearson TC, Larsen CP.

Am J Transplant. 2017 Nov;17(11):2922-2936. doi: 10.1111/ajt.14353. Epub 2017 Jul 3.

18.

Decisional conflict between treatment options among end-stage renal disease patients evaluated for kidney transplantation.

McPherson L, Basu M, Gander J, Pastan SO, Mohan S, Wolf MS, Chiles M, Russell A, Lipford K, Patzer RE.

Clin Transplant. 2017 Jul;31(7). doi: 10.1111/ctr.12991. Epub 2017 May 29.

PMID:
28457025
19.

Decreasing Estimated Glomerular Filtration Rate Is Associated With Increased Risk of Hospitalization After Kidney Transplantation.

Keong FM, Afshar YA, Pastan SO, Chowdhury R, Binongo JN, Patzer RE.

Kidney Int Rep. 2016 Nov;1(4):269-278. doi: 10.1016/j.ekir.2016.08.008. Epub 2016 Aug 18.

20.

Predictive Value of Using Initial Versus Terminal Deceased Donor Creatinine to Calculate the Kidney Donor Risk Index.

Chiles MC, Husain SA, Skillen W, Lee S, Carpenter D, Pastan SO, Patzer RE, Tanriover B, Mohan S.

Am J Kidney Dis. 2017 Jul;70(1):153-154. doi: 10.1053/j.ajkd.2017.02.373. Epub 2017 Apr 14. No abstract available.

PMID:
28416320
21.

Preventing Emergency Department Use among Patients with CKD: It Starts with Awareness.

Patzer RE, Schrager JD, Pastan SO.

Clin J Am Soc Nephrol. 2017 Feb 7;12(2):225-227. doi: 10.2215/CJN.12881216. Epub 2017 Jan 24. No abstract available.

22.

Referral for Kidney Transplantation and Indicators of Quality of Dialysis Care: A Cross-sectional Study.

Plantinga LC, Pastan SO, Wilk AS, Krisher J, Mulloy L, Gibney EM, Patzer RE.

Am J Kidney Dis. 2017 Feb;69(2):257-265. doi: 10.1053/j.ajkd.2016.08.038. Epub 2016 Nov 20.

23.

Effect of Replacing Race With Apolipoprotein L1 Genotype in Calculation of Kidney Donor Risk Index.

Julian BA, Gaston RS, Brown WM, Reeves-Daniel AM, Israni AK, Schladt DP, Pastan SO, Mohan S, Freedman BI, Divers J.

Am J Transplant. 2017 Jun;17(6):1540-1548. doi: 10.1111/ajt.14113. Epub 2017 Jan 3.

24.

A Randomized Trial to Reduce Disparities in Referral for Transplant Evaluation.

Patzer RE, Paul S, Plantinga L, Gander J, Sauls L, Krisher J, Mulloy LL, Gibney EM, Browne T, Zayas CF, McClellan WM, Arriola KJ, Pastan SO; Southeastern Kidney Transplant Coalition.

J Am Soc Nephrol. 2017 Mar;28(3):935-942. doi: 10.1681/ASN.2016030320. Epub 2016 Oct 13.

25.

Emergency Department Use and Hospital Admissions Among Patients With End-Stage Renal Disease in the United States.

Lovasik BP, Zhang R, Hockenberry JM, Schrager JD, Pastan SO, Mohan S, Patzer RE.

JAMA Intern Med. 2016 Oct 1;176(10):1563-1565. doi: 10.1001/jamainternmed.2016.4975. No abstract available.

PMID:
27548699
26.

Everybody needs a cheerleader to get a kidney transplant: a qualitative study of the patient barriers and facilitators to kidney transplantation in the Southeastern United States.

Browne T, Amamoo A, Patzer RE, Krisher J, Well H, Gander J, Pastan SO.

BMC Nephrol. 2016 Jul 30;17(1):108. doi: 10.1186/s12882-016-0326-3.

27.

Comparison of vascular access outcomes in patients with end-stage renal disease attributed to systemic lupus erythematosus vs. other causes: a retrospective cohort study.

Plantinga LC, Lim SS, Patzer RE, Pastan SO, Drenkard C.

BMC Nephrol. 2016 Jul 7;17(1):64. doi: 10.1186/s12882-016-0274-y.

28.

The weekend effect alters the procurement and discard rates of deceased donor kidneys in the United States.

Mohan S, Foley K, Chiles MC, Dube GK, Patzer RE, Pastan SO, Crew RJ, Cohen DJ, Ratner LE.

Kidney Int. 2016 Jul;90(1):157-63. doi: 10.1016/j.kint.2016.03.007. Epub 2016 May 12.

29.

Deceased-Donor Apolipoprotein L1 Renal-Risk Variants Have Minimal Effects on Liver Transplant Outcomes.

Dorr CR, Freedman BI, Hicks PJ, Brown WM, Russell GB, Julian BA, Pastan SO, Gautreaux MD, Muthusamy A, Chinnakotla S, Hauptfeld V, Bray RA, Kirk AD, Divers J, Israni AK.

PLoS One. 2016 Apr 7;11(4):e0152775. doi: 10.1371/journal.pone.0152775. eCollection 2016.

30.

Attribution of cause of end-stage renal disease among patients with systemic lupus erythematosus: the Georgia Lupus Registry.

Plantinga LC, Drenkard C, Pastan SO, Lim SS.

Lupus Sci Med. 2016 Jan 22;3(1):e000132. doi: 10.1136/lupus-2015-000132. eCollection 2016.

31.

Racial/Ethnic Differences in the Association Between Hospitalization and Kidney Transplantation Among Waitlisted End-Stage Renal Disease Patients.

Newman KL, Fedewa SA, Jacobson MH, Adams AB, Zhang R, Pastan SO, Patzer RE.

Transplantation. 2016 Dec;100(12):2735-2745.

32.

iChoose Kidney: A Clinical Decision Aid for Kidney Transplantation Versus Dialysis Treatment.

Patzer RE, Basu M, Larsen CP, Pastan SO, Mohan S, Patzer M, Konomos M, McClellan WM, Lea J, Howard D, Gander J, Arriola KJ.

Transplantation. 2016 Mar;100(3):630-9. doi: 10.1097/TP.0000000000001019.

33.

APOL1 Genotype and Kidney Transplantation Outcomes From Deceased African American Donors.

Freedman BI, Pastan SO, Israni AK, Schladt D, Julian BA, Gautreaux MD, Hauptfeld V, Bray RA, Gebel HM, Kirk AD, Gaston RS, Rogers J, Farney AC, Orlando G, Stratta RJ, Mohan S, Ma L, Langefeld CD, Bowden DW, Hicks PJ, Palmer ND, Palanisamy A, Reeves-Daniel AM, Brown WM, Divers J.

Transplantation. 2016 Jan;100(1):194-202. doi: 10.1097/TP.0000000000000969.

34.

Dialysis Facility Transplant Philosophy and Access to Kidney Transplantation in the Southeast.

Gander J, Browne T, Plantinga L, Pastan SO, Sauls L, Krisher J, Patzer RE.

Am J Nephrol. 2015;41(6):504-11. doi: 10.1159/000438463. Epub 2015 Aug 6.

35.

Variation in Dialysis Facility Referral for Kidney Transplantation Among Patients With End-Stage Renal Disease in Georgia.

Patzer RE, Plantinga LC, Paul S, Gander J, Krisher J, Sauls L, Gibney EM, Mulloy L, Pastan SO.

JAMA. 2015 Aug 11;314(6):582-94. doi: 10.1001/jama.2015.8897.

36.

Geographic variation and neighborhood factors are associated with low rates of pre-end-stage renal disease nephrology care.

Hao H, Lovasik BP, Pastan SO, Chang HH, Chowdhury R, Patzer RE.

Kidney Int. 2015 Sep;88(3):614-21. doi: 10.1038/ki.2015.118. Epub 2015 Apr 22.

PMID:
25901471
37.

Comparison of quality-of-care measures in U.S. patients with end-stage renal disease secondary to lupus nephritis vs. other causes.

Plantinga LC, Patzer RE, Drenkard C, Pastan SO, Cobb J, McClellan W, Lim SS.

BMC Nephrol. 2015 Mar 29;16:39. doi: 10.1186/s12882-015-0037-1.

38.

Deceased donor multidrug resistance protein 1 and caveolin 1 gene variants may influence allograft survival in kidney transplantation.

Ma J, Divers J, Palmer ND, Julian BA, Israni AK, Schladt D, Pastan SO, Chattrabhuti K, Gautreaux MD, Hauptfeld V, Bray RA, Kirk AD, Brown WM, Gaston RS, Rogers J, Farney AC, Orlando G, Stratta RJ, Guan M, Palanisamy A, Reeves-Daniel AM, Bowden DW, Langefeld CD, Hicks PJ, Ma L, Freedman BI.

Kidney Int. 2015 Sep;88(3):584-92. doi: 10.1038/ki.2015.105. Epub 2015 Apr 8.

39.

Apolipoprotein L1 gene variants in deceased organ donors are associated with renal allograft failure.

Freedman BI, Julian BA, Pastan SO, Israni AK, Schladt D, Gautreaux MD, Hauptfeld V, Bray RA, Gebel HM, Kirk AD, Gaston RS, Rogers J, Farney AC, Orlando G, Stratta RJ, Mohan S, Ma L, Langefeld CD, Hicks PJ, Palmer ND, Adams PL, Palanisamy A, Reeves-Daniel AM, Divers J.

Am J Transplant. 2015 Jun;15(6):1615-22. doi: 10.1111/ajt.13223. Epub 2015 Mar 24.

40.

The RaDIANT community study protocol: community-based participatory research for reducing disparities in access to kidney transplantation.

Patzer RE, Gander J, Sauls L, Amamoo MA, Krisher J, Mulloy LL, Gibney E, Browne T, Plantinga L, Pastan SO; Southeastern Kidney Transplant Coalition.

BMC Nephrol. 2014 Oct 28;15:171. doi: 10.1186/1471-2369-15-171.

41.

Association of time to kidney transplantation with graft failure among U.S. patients with end-stage renal disease due to lupus nephritis.

Plantinga LC, Patzer RE, Drenkard C, Kramer MR, Klein M, Lim SS, McClellan WM, Pastan SO.

Arthritis Care Res (Hoboken). 2015 Apr;67(4):571-81. doi: 10.1002/acr.22482.

42.

Dialysis facility and network factors associated with low kidney transplantation rates among United States dialysis facilities.

Patzer RE, Plantinga L, Krisher J, Pastan SO.

Am J Transplant. 2014 Jul;14(7):1562-72. doi: 10.1111/ajt.12749. Epub 2014 May 29.

43.

Kidney transplant access in the Southeast: view from the bottom.

Patzer RE, Pastan SO.

Am J Transplant. 2014 Jul;14(7):1499-505. doi: 10.1111/ajt.12748. Epub 2014 May 29.

44.

Measuring the disparity gap: quality improvement to eliminate health disparities in kidney transplantation.

Patzer RE, Pastan SO.

Am J Transplant. 2013 Feb;13(2):247-8. doi: 10.1111/ajt.12060. Epub 2013 Jan 17. No abstract available.

45.

Membranous nephropathy associated with gastrointestinal stromal tumour: a case report.

Cimic A, Pastan SO, Bijol V.

NDT Plus. 2009 Aug;2(4):306-8. doi: 10.1093/ndtplus/sfp028. Epub 2009 Mar 4.

46.

Cardiac disease in patients with end-stage renal disease.

Staffeld CG, Pastan SO.

Cardiol Clin. 1995 May;13(2):209-23. Review.

PMID:
7614511
47.

Urea kinetics during continuous hemofiltration.

Clark WR, Murphy MH, Alaka KJ, Mueller BA, Pastan SO, Macias WL.

ASAIO J. 1992 Jul-Sep;38(3):M664-7.

PMID:
1457944

Supplemental Content

Loading ...
Support Center